department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Adquey · pharmadog

pharmadog
drugs
Adquey

drug

patient view →

difamilast

Marketedupdated 2mo ago

by Acrotech Biopharma Inc

Approved

community read0 votes

all catalysts(1)

approval · 1

ADQUEY (DIFAMILAST) — FDA approval

News(0)

no news has mentioned this drug yet

brand

Adquey

generic

difamilast

indication

Atopic Dermatitis (Atopic Eczema)

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Mar 1, 2028

~1.7 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

Dec 31, 2036compositionUS 10588893
Mar 1, 2028compositionUS RE467921.7y

FDA exclusivities (1)

Feb 12, 2031NCENew Chemical Entity (5y)4.6y

Data sources

openFDA · ClinicalTrials.gov

last refreshed 31m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 3

tagApproval4 co-mentions · 1 sources
drugADQUEY4 co-mentions · 1 sources
companyAcrotech Biopharma Inc2 co-mentions · 1 sources

Trials studying difamilast

phase3This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)completedn=153
phase3A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitiscompletedn=542